Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

The CBO found another way the Senate tax bill benefits higher-income Americans over the rest

Cuts to Medicaid, Obamacare subsidies, and other spending.

WASHINGTON, DC - SEPTEMBER 27:  U.S. Senate Majority Leader Sen. Mitch McConnell (R-KY) (R) listens to Sen. Orrin Hatch (R-UT) (L) as they attend a press event on tax reform other congressional Republicans September 27, 2017 at the Capitol in Washington,
WASHINGTON, DC - SEPTEMBER 27:  U.S. Senate Majority Leader Sen. Mitch McConnell (R-KY) (R) listens to Sen. Orrin Hatch (R-UT) (L) as they attend a press event on tax reform other congressional Republicans September 27, 2017 at the Capitol in Washington,
Alex Wong/Getty Images
Dylan Scott
Dylan Scott covers health for Vox, guiding readers through the emerging opportunities and challenges in improving our health. He has reported on health policy for more than 10 years, writing for Governing magazine, Talking Points Memo, and STAT before joining Vox in 2017.

The Senate tax bill would provide more tax benefits to higher-income Americans than the middle-class or lower-income people. But in another odd quirk of the plan, which now also repeals Obamacare’s individual mandate, federal spending on lower-income Americans is also projected to significantly decline.

Released by the Congressional Budget Office late on Friday, it’s a new finding that further exacerbates the Republican plan’s tendency to reward wealthier Americans at the expense of the rest.

This shift in federal spending stems from the Senate’s decision to add the repeal of the individual mandate, the health care law’s requirement that Americans have insurance or pay a penalty to their bill. The CBO already reported the mandate’s repeal would lead to 13 million fewer Americans having insurance and a $338 billion total federal spending cut by 2027, compared to current law.

But that drop in Americans with insurance would have residual effects on federal spending outside of reduced spending on Obamacare’s tax subsidies, which people can use to buy private coverage on the law’s marketplaces. The CBO calculated those other aftereffects — excluding the cut to tax subsidies, which are available to people making 400 percent of poverty, about $48,000 for an individual — in its new report.

As this table makes clear, the net result is less federal spending for lower-income Americans and more spending for higher-income Americans:

Congressional Budget Office

The CBO estimated that Medicaid spending in 2021 would be cut by $18 billion, versus current law; millions fewer Americans are projected to be enrolled in the program without the mandate. There would also be reductions in federal payments for cost-sharing reductions, which compensate insurers for required discounts that they must provide to lower-income customers, and another Obamacare fund that allows states to set up their own insurance programs for poorer residents.

See More:

More in Politics

Podcasts
The Supreme Court abortion pills case, explainedThe Supreme Court abortion pills case, explained
Podcast
Podcasts

How Louisiana brought mifepristone back to SCOTUS.

By Peter Balonon-Rosen and Sean Rameswaram
Politics
Trump’s China policy is nearly the exact opposite of what everyone expectedTrump’s China policy is nearly the exact opposite of what everyone expected
Politics

As Trump heads to China, attention and resources are being shifted from Asia to yet another war in the Middle East.

By Joshua Keating
Politics
Are far-right politics just the new normal?Are far-right politics just the new normal?
Politics

Liberals are preparing for a longer war with right-wing populists than they once expected.

By Zack Beauchamp
The Logoff
Flavored vapes doomed Trump’s FDA headFlavored vapes doomed Trump’s FDA head
The Logoff

Why Marty Makary is out at the FDA, briefly explained.

By Cameron Peters
Politics
Virginia Democrats’ irresponsible new plan to save their gerrymanderVirginia Democrats’ irresponsible new plan to save their gerrymander
Politics

Democrats just handed the Supreme Court’s Republicans a loaded weapon.

By Ian Millhiser
The Logoff
Can Trump lower gas prices?Can Trump lower gas prices?
The Logoff

What suspending the gas tax would mean for you, briefly explained.

By Cameron Peters